COMMUNIQUÉS West-GlobeNewswire

SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences
23/06/2026
NORTH PALM BEACH, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”) today announced a strategic investment in ARMR Sciences, a clinical-stage biodefense company [...]
Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer
23/06/2026
REDWOOD CITY, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it has [...]
Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication
23/06/2026
Publication of MONITOR-Breast study marks latest milestone for clinical validity of Precise MRD SALT LAKE CITY, June 23, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic [...]
EssilorLuxottica et Meta étendent l’accès à la catégorie des wearables avec une nouvelle collection
23/06/2026
EssilorLuxottica et Meta étendent l’accès à la catégorie des wearables avec une nouvelle collection Fortes d’un portefeuille de lunettes IA faisant référence, les deux entreprises visent à apporter l'innovation des [...]
CoreHealth Announces Leadership Transition as Charles Martin Appointed Chief Executive Officer
23/06/2026
TORONTO, June 23, 2026 (GLOBE NEWSWIRE) -- CoreHealth Technologies Inc. today announced that Michael Peters will conclude his tenure as Chief Executive Officer at the end of June, following five years of leadership that [...]
Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production
23/06/2026
Engineered from the genomes of multiple butterfly species, Chrysalis transposase achieves fast cell recovery, stable expression over 60 cellular generations, and high expression across transgenes. In recent customer [...]
MannKind Awarded Breakthrough T1D Grant to Support Advancement of INHALE-1ST Pediatric Trial of Afrezza® in Youth with Newly-Diagnosed T1D
23/06/2026
Collaboration underscores interest in inhaled insulin and strengthens bringing innovation and new options to pediatric diabetes care DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- [...]
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
23/06/2026
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the [...]
Tria Federal Appoints Former CMS and IRS CIO Rajiv Uppal to Advisory Board
23/06/2026
ARLINGTON, Va., June 23, 2026 (GLOBE NEWSWIRE) -- Tria Federal today announced the appointment of Rajiv Uppal, former Chief Information Officer of the Centers for Medicare & Medicaid Services (CMS) and the Internal [...]
Integra LifeSciences Announces Key Executive Appointments
23/06/2026
Leadership appointments reinforce company’s commitment to enhancing commercial execution and deepening customer engagement, while building leadership depth PRINCETON, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Integra [...]
Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel
23/06/2026
- First glioblastoma patient ever treated with Alpha DaRT® outside of the United States, and the first in Israel - performed at Hadassah University Medical Center in Jerusalem, one of the world’s premier academic [...]
Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
23/06/2026
CTA Approval from Germany's Federal Institute for Drugs and Medical Devices (BfArM), accompanied by a positive opinion from the Ethics Committee of the North Rhine Medical Association, clears Silexion to initiate the [...]
Berry Street and Tia Partner to Deliver Clinical Nutrition Therapy at Every Stage of a Woman's Life
23/06/2026
Tia members gain access to Berry Street's AI-powered platform and network of 1,800+ Registered Dietitians specializing in women's health NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Berry Street , the leading metabolic [...]
Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia
23/06/2026
Agreement Marks Company’s Expansion into Precision Oncology Testing, with the Goal of Establishing Malaysia's First Clinically Validated PDO Platform KUALA LUMPUR, Malaysia, June 23, 2026 (GLOBE NEWSWIRE) -- Alps Group [...]
SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
23/06/2026
Enables standardized inpatient hospital billing for QUELIMMUNE ® (SCD-PED) therapy Universal code paves the way for billing of future potential SCD therapies requiring renal replacement therapy DENVER, June 23, 2026 ( [...]
IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification
23/06/2026
On track for enrollment of 80 participants by Q1 2027 Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer Novel immunotherapy [...]
Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach
23/06/2026
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the [...]
SK pharmteco Announces SKyvec™, A Unified, High-Yield Viral Vector Platform Designed to Accelerate Gene Therapy Development from Batch to Bedside
23/06/2026
RANCHO CORDOVA, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced the launch of SKyvec™, its proprietary, multimodal viral vector platform. Designed to support gene therapy programs at every stage, [...]
The XLH Network and Kyowa Kirin Launch the XLH Community Guidebook to Help People Navigate Lifelong Journey with XLH
23/06/2026
New online resource brings together practical information, community perspectives, and expert guidance tailored to people with XLH across ages and life stages PRINCETON, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Kyowa [...]

Pages